A Pilot Test for Newly Developed Synoptic Operative Template for Ovarian Cancer (SOTOC): National Cancer Center - Peritoneal Carcinomatosis Index
NCT01823731 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2013-06-05
Summary
objectives: To development of NCC-PCI-Operative Template (NPOT) for the objective description of perioperative tumor burden and surgical approaches in the management of ovarian cancer, tubal cancer, and primary peritoneal cancer
Conditions
Sponsors & Collaborators
-
National Cancer Center, Korea
lead OTHER_GOV
Eligibility
- Min Age
- 20 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2013-12-31
- Completion
- 2013-12-31
More Related Trials
-
Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)
NCT03983226 ·Status: RECRUITING ·Phase: PHASE2
-
A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
NCT01570582 ·Status: UNKNOWN ·Phase: PHASE2
-
Comparative Effectiveness of HIPEC Following Interval Debulking Surgery in Patients With Advanced-stage Ovarian Cancer
NCT03448354 ·Status: UNKNOWN ·Phase: NA
-
Ovarian Cancer Radiomics Approach in CT Led Evaluation
NCT06817174 ·Status: RECRUITING
-
Treatment for Malignant Ovarian Cancer: Laparoscopy vs Laparotomy
NCT02686463 ·Status: UNKNOWN ·Phase: NA
-
Secondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor Maintenance
NCT05704621 ·Status: RECRUITING ·Phase: PHASE2
-
Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer
NCT06535334 ·Status: NOT_YET_RECRUITING
-
IPHC in Patients With Platinum-sensitive Recurrent Ovarian Cancer
NCT01588964 ·Status: COMPLETED ·Phase: PHASE2
-
Intraoperative Hyperthermic Intraperitoneal Chemotherapy With Ovarian Cancer
NCT01091636 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer
NCT05236686 ·Status: RECRUITING ·Phase: NA
-
Development of a Patient Reported Outcome Measure for Advanced Ovarian Cancer Patients Receiving Surgical and Chemotherapy Treatment
NCT05274867 ·Status: UNKNOWN
-
Tolerance, Safety, Efficacy, and Pharmacokinetics of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel for Platinum-resistant Recurrent Ovarian Cancer
NCT07273396 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Surgery for Relapsed Ovarian Cancer in Precision
NCT06602063 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
A Study of Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of Care
NCT04834544 ·Status: RECRUITING ·Phase: PHASE2
-
CRS & HIPEC for Platinum-Resistant Recurrent Ovarian Cancer (KOV-02R, RECOVER)
NCT05316181 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Trial of Best Supportive Care and Either Cisplatin or Paclitaxel to Treat Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer and Inoperable Malignant Bowel Obstruction
NCT01083537 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Trial of Chemotherapy in Ovarian, Fallopian Tube and Peritoneal Carcinoma
NCT01519869 ·Status: COMPLETED ·Phase: PHASE2
-
Primary Cyto-reductive Surgery Vs Neo-adjuvant Chemotherapy (NAC) in Epithelial Ovarian Cancer
NCT04257786 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of HIPEC as NACT and Postoperative Chemotherapy in the Treatment of Advanced-Stage Epithelial Ovarian Cancer
NCT03180177 ·Status: UNKNOWN ·Phase: PHASE3
-
Dose-dense Chemotherapy Versus Intraperitoneal Chemotherapy as First-line Chemotherapy in Advanced Ovarian Cancer
NCT04135521 ·Status: COMPLETED
-
Topotecan in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
NCT00055614 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer
NCT00267696 ·Status: COMPLETED ·Phase: PHASE2
-
Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
NCT00003345 ·Status: COMPLETED ·Phase: PHASE2
-
Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
NCT01074411 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer
NCT05371301 ·Status: UNKNOWN ·Phase: PHASE3